Swiss - Delayed Quote • CHF
Siegfried Holding AG (SFZN.SW)
At close: 5:31 PM GMT+2
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 10 | 10 |
| Avg. Estimate | 0 | 0 | 34.25 | 39.6 |
| Low Estimate | 0 | 0 | 32.14 | 36.5 |
| High Estimate | 0 | 0 | 36.8 | 42.36 |
| Year Ago EPS | -- | -- | 26.22 | 34.25 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 10 | 10 |
| Avg. Estimate | -- | -- | 1.3B | 1.41B |
| Low Estimate | -- | -- | 1.28B | 1.37B |
| High Estimate | -- | -- | 1.33B | 1.45B |
| Year Ago Sales | -- | -- | 1.27B | 1.3B |
| Sales Growth (year/est) | -- | -- | 2.30% | 8.30% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 34.25 | 39.6 |
| 7 Days Ago | 0 | 0 | 34.43 | 39.96 |
| 30 Days Ago | 0 | 0 | 34.42 | 39.95 |
| 60 Days Ago | 0 | 0 | 34.42 | 39.95 |
| 90 Days Ago | 0 | 0 | 34.43 | 39.79 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | SFZN.SW | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 9.10% |
| Next Qtr. | -- | -- | -- | 11.50% |
| Current Year | 30.60% | -- | -- | 5.70% |
| Next Year | 15.60% | -- | -- | 12.60% |
| Next 5 Years (per annum) | 1.36% | -- | -- | 11.34% |
| Past 5 Years (per annum) | 9.20% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Related Tickers
HIK.L Hikma Pharmaceuticals PLC
1,930.00
-0.97%
HLUN-B.CO H. Lundbeck A/S
37.00
+0.22%
EVRRF Molecule Holdings Inc.
0.0025
0.00%
U5Z.F Vertical Peak Holdings Inc.
0.0005
0.00%
RPGLF Regent Pacific Group Limited
0.0600
-11.76%
LDE.DU Lifecore Biomedical Inc
5.35
-0.93%
CRPGF CHINA RESOURCES PHARMACEUTICAL
0.5600
0.00%
MITPF Mithra Pharmaceuticals SA
6.75
-12.90%
RPG.F Regent Pacific Group Limited
0.0675
+3.85%
DCPXF DanCann Pharma A/S
0.0100
0.00%